Public injecting and its association with mental health and other drug-related outcomes among people who inject drugs in Iran [0.03%]
伊朗注射吸毒者公共注射及其与精神健康和其他吸毒相关结果之间的联系
Mehrdad Khezri,Fatemeh Tavakoli,Mohammad Karamouzian et al.
Mehrdad Khezri et al.
Background: Injecting in public places may increase the risk of drug and health-related harms among people who inject drugs (PWID). We examined the prevalence of public injecting and associations with non-fatal overdose, ...
The impact of race, gender, and heroin use on opioid addiction stigma [0.03%]
种族、性别和海洛因使用对阿片类药物成瘾污名化的影响
Kimberly Goodyear,Jasjit Ahluwalia,David Chavanne
Kimberly Goodyear
Introduction: Stigmatization of an opioid addiction acts as a barrier to those seeking substance use treatment. As opioid use and overdoses continue to rise and affect minority populations, understanding the impact that r...
Randomized Controlled Trial
Journal of substance abuse treatment. 2022 Dec:143:108872. DOI:10.1016/j.jsat.2022.108872 2022
Disease and decision [0.03%]
疾病与决策
Kirsten E Smith
Kirsten E Smith
At age 16, I injected morphine for the first time, and then started injecting heroin. By most standards, I was highly functioning, although I eventually became addicted. I was and remain socioeconomically privileged, but my relationship to ...
Opioid relapse and MOUD outcomes following civil commitment for opioid use [0.03%]
强制治疗对阿片类药物使用障碍患者复发及药物维持治疗效果的影响研究
Jumi Hayaki,Haley Cinq-Mars,Paul P Christopher et al.
Jumi Hayaki et al.
Introduction: Opioid use disorder (OUD) continues to present a major public health problem in the United States. Civil commitment for substance use is one mandatory form of treatment for severe opioid use that has become ...
Toby Lynch,Windia Rodriguez,David Eddie
Toby Lynch
Stigma thrives in vacuums of awareness where stereotypes are allowed to persist. When those of us with lived experience of addiction and addiction recovery stay in the shadows, we miss an opportunity to challenge a harmful narrative-that pe...
Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study [0.03%]
住院药物清除治疗后的物质使用障碍治疗障碍：一项定性研究
Allison R David,Carlos R Sian,Christina M Gebel et al.
Allison R David et al.
Introduction: Access to and uptake of evidence-based treatment for substance use disorder, specifically opioid use disorder (OUD), are limited despite the high death toll from drug overdose in the United States in recent ...
A randomized pilot trial of a mobile phone-based brief intervention with personalized feedback and interactive text messaging to reduce driving after cannabis use and riding with a cannabis impaired driver [0.03%]
一种基于手机的简短干预措施的随机试点试验，该措施具有个性化反馈和互动短信功能，可减少因使用大麻而驾驶以及与受大麻影响的驾驶员一起乘车的行为
Jenni B Teeters,Nicole M Armstrong,Shelby A King et al.
Jenni B Teeters et al.
Introduction: Driving after cannabis use (DACU) and riding with a cannabis-impaired driver (RWCD) are national public health concerns. Though driving impairments and increased crash risk make DACU and RWCD two of the risk...
Randomized Controlled Trial
Journal of substance abuse treatment. 2022 Nov:142:108867. DOI:10.1016/j.jsat.2022.108867 2022
Influences of poly-victimization on adolescents' pre-treatment cognitive motivations and post-treatment outcomes [0.03%]
多victimization对青少年治疗前认知动机和治疗后结果的影响
Nina C Christie,Graham DiGuiseppi,Sheila Pakdaman et al.
Nina C Christie et al.
Introduction: Substance use treatment outcomes are challenging to predict: myriad potentially relevant factors influence outcomes, including age, sex, motivations, and history of victimization. ...
Recidivism prevention for impaired driving: Longitudinal 5-year outcomes from Quebec's severity-based intervention assignment program [0.03%]
魁北克基于危害程度的干预分配项目的纵向五年Outcome：醉酒驾车再犯预防
Thomas G Brown,Nathaniel Moxley-Kelly,Marie Claude Ouimet
Thomas G Brown
Introduction: Driving while impaired by alcohol (DWI) is a persistent problem. Tailoring intervention modality to client risk and needs (i.e., risk/needs) is posited to both reduce recidivism more efficiently than uniform...
Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder [0.03%]
长效纳曲酮维持治疗与司法管辖区内的阿片类药物使用障碍患者的减量注射式阿片类药物使用相关
Audun J Lier,Nikhil Seval,Brent Vander Wyk et al.
Audun J Lier et al.
Introduction: Opioid use disorder (OUD) and injection drug use (IDU) place justice-involved individuals at increased risk for acquiring or transmitting HIV or hepatitis C virus (HCV). Methadone and buprenorphine have been...
Randomized Controlled Trial
Journal of substance abuse treatment. 2022 Nov:142:108852. DOI:10.1016/j.jsat.2022.108852 2022